Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Merav Zohar"'
Autor:
Emmet B. Keeffe, Norah A. Terrault, D. Terkieltaub, Eithan Galun, Edith Matot, Yaffa Ashour, Daniel Shouval, Sara Mizrachi, Shlomo Dagan, Rachel Eren, Rifaat Safadi, Ido Lubin, Merav Zohar, Judith Gopher
Publikováno v:
Hepatology. 35:673-679
Treatment of chronic hepatitis B virus (HBV) infection with interferon alfa and lamivudine is characterized by lack of viral clearance, loss of response, or emergence of drug-resistant mutants. Thus, new and multiple drug approaches are needed. We ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9217e6caaf69b2dc07870e2c68df97dd
https://doi.org/10.1053/jhep.2002.31867
https://doi.org/10.1053/jhep.2002.31867
Autor:
Eithan, Galun, Rachel, Eren, Rifaat, Safadi, Yaffa, Ashour, Norah, Terrault, Emmet B, Keeffe, Edith, Matot, Sara, Mizrachi, Dov, Terkieltaub, Merav, Zohar, Ido, Lubin, Judith, Gopher, Daniel, Shouval, Shlomo, Dagan
Publikováno v:
Hepatology (Baltimore, Md.). 35(3)
Treatment of chronic hepatitis B virus (HBV) infection with interferon alfa and lamivudine is characterized by lack of viral clearance, loss of response, or emergence of drug-resistant mutants. Thus, new and multiple drug approaches are needed. We ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6ac76f53d664511f93803b5233dc38fa
https://pubmed.ncbi.nlm.nih.gov/11870383
https://pubmed.ncbi.nlm.nih.gov/11870383